DC
SRPT icon

Diametric Capital’s Sarepta Therapeutics SRPT Stock Holding History

Diametric Capital’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,406
Closed -$298K – 475
2025
Q2 		$298K Buy
+17,406
New +$743K 0.16% 181
2024
Q2 		– Sell
-1,717
Closed -$222K – 463
2024
Q1 		$222K Sell
1,717
-2,851
-62% -$349K 0.12% 233
2023
Q4 		$440K Sell
4,568
-17,089
-79% -$1.64M 0.27% 120
2023
Q3 		$2.63M Buy
21,657
+8,517
+65% +$963K 1.1% 12
2023
Q2 		$1.5M Buy
13,140
+7,229
+122% +$932K 0.67% 35
2023
Q1 		$815K Buy
+5,911
New +$767K 0.39% 75
2020
Q3 		– Sell
-5,774
Closed -$926K – 173
2020
Q2 		$926K Buy
5,774
+2,645
+85% +$360K 0.71% 59
2020
Q1 		$306K Buy
+3,129
New +$358K 0.37% 75
2019
Q3 		– Sell
-1,634
Closed -$248K – 135
2019
Q2 		$248K Sell
1,634
-1,820
-53% -$221K 0.16% 100
2019
Q1 		$412K Buy
3,454
+1,386
+67% +$178K 0.32% 73
2018
Q4 		$226K Buy
2,068
+379
+22% +$47.4K 0.17% 93
2018
Q3 		$273K Buy
+1,689
New +$231K 0.24% 88
2018
Q2 		– Sell
-7,840
Closed -$581K – 98
2018
Q1 		$581K Sell
7,840
-12,142
-61% -$810K 0.44% 64
2017
Q4 		$1.11M Buy
+19,982
New +$1.06M 0.67% 64

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Diametric Capital's SRPT Position: Q3 2025 in Review

Diametric Capital sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 17,406 shares — an estimated $298K sold.

Diametric Capital first reported a position in SRPT in Q4 2017 and held it in 14 quarters. The position peaked at $2.63M in Q3 2023. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • Diametric Capital reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Diametric Capital sold 17,406 Sarepta Therapeutics shares in Q3 2025, an estimated $298K.
  • Diametric Capital first reported a position in Sarepta Therapeutics in Q4 2017 and held it in 14 quarters.
  • Diametric Capital's Sarepta Therapeutics position peaked at $2.63M in Q3 2023.
  • 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Diametric Capital's 13F filing for Q3 2025, filed 13 Nov 2025.